Brendan O’Leary
Senior Vice President of FinanceMr. Brendan O’Leary, C.F.A., is Senior Vice President of Finance of Insmed Incorporated from 2026. Mr. O’Leary joined the Insmed Incorporated in November 2023. Mr. O’Leary serves as Chief Operating Officer at Xalud Therapeutics, Inc. since May 2021. He bring his demonstrated leadership in finance, strategy and commercial operations to guide the company’s strategic direction and business support functions. Brendan previously had an accomplished many years career at Pfizer where he most recently served as the general manager of Greenstone LLC, the top authorized generics company in the US. Prior to this, he led strategy and commercial operations for business in Pfizer Essential Health and had key roles in corporate finance and business leadership during Pfizer’s transformation over the last decade. He holds an MBA from the Frank Zarb School of Business at Hofstra University.
Positions
- Company NameInsmed IncorporatedStock CodeINSMPositionSenior Vice President of FinanceColleagues
- WHWilliam H. LewisPresident, CEO & Chairman
- RARoger AdsettChief Operating Officer
- MAMichael Alexander SmithChief Legal Officer & Corporate Secretary
- MFMartina FlammerChief Medical Officer
- DRDavid R. BrennanLead Independent Director
- CACarol A. SchaferIndependent Director
- MSMelvin SharokyIndependent Director
- LLLeo LeeIndependent Director
